MERRIMACK PHARMACEUTICALS INC Income (Loss) from Continuing Operations, Per Basic and Diluted Share
MERRIMACK PHARMACEUTICALS INC reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of -$0.23 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-10.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2021-03-10
- MERRIMACK PHARMACEUTICALS INC income (loss) from continuing operations, per basic and diluted share for the quarter ending 2018-12-31 was -$0.97.
- MERRIMACK PHARMACEUTICALS INC income (loss) from continuing operations, per basic and diluted share for the quarter ending 2018-09-30 was -$0.92.
- MERRIMACK PHARMACEUTICALS INC income (loss) from continuing operations, per basic and diluted share for the quarter ending 2018-06-30 was -$1.33.
- MERRIMACK PHARMACEUTICALS INC income (loss) from continuing operations, per basic and diluted share for the quarter ending 2018-03-31 was -$1.33.
- MERRIMACK PHARMACEUTICALS INC income (loss) from continuing operations, per basic and diluted share for fiscal 2020 was -$0.23.
- MERRIMACK PHARMACEUTICALS INC income (loss) from continuing operations, per basic and diluted share for fiscal 2019 was -$1.59.
- MERRIMACK PHARMACEUTICALS INC income (loss) from continuing operations, per basic and diluted share for fiscal 2018 was -$4.55.
- MERRIMACK PHARMACEUTICALS INC income (loss) from continuing operations, per basic and diluted share for fiscal 2017 was -$5.66.
| Period end | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 0 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 12 month |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$0.23 10-K · filed 2021-03-10 | ||||||
| 2019-12-31 | -$0.05 10-Q · filed 2019-11-12 | -$1.59 10-K · filed 2021-03-10 | |||||
| 2019-09-30 | -$1.54 10-Q · filed 2019-11-12 | ||||||
| 2018-12-31 | -$0.97 10-K · filed 2019-03-06 | -$4.55 10-K · filed 2020-03-12 | |||||
| 2018-09-30 | -$0.92 10-Q · filed 2019-11-12 | -$3.59 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | -$1.33 10-K · filed 2019-03-06 | -$2.66 10-Q · filed 2018-08-07 | |||||
| 2018-03-31 | -$1.33 10-K · filed 2019-03-06 | ||||||
| 2017-12-31 | -$0.89 10-K · filed 2019-03-06 | -$5.66 10-K · filed 2019-03-06 | |||||
| 2017-09-30 | -$0.40 10-K · filed 2019-03-06 | -$4.77 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | -$2.18 10-K · filed 2019-03-06 | -$0.22 10-Q · filed 2017-08-09 | -$4.38 10-Q · filed 2018-08-07 | -$0.44 10-Q · filed 2017-08-09 | |||
| 2017-03-31 | -$2.20 10-K · filed 2019-03-06 | -$0.22 10-Q · filed 2017-05-10 | |||||
| 2016-12-31 | -$2.93 10-K · filed 2018-03-12 | -$12.33 10-K · filed 2018-03-12 | |||||
| 2016-09-30 | -$2.06 10-K · filed 2018-03-12 | -$9.33 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | -$4.07 10-K · filed 2018-03-12 | -$0.41 10-Q · filed 2017-08-09 | -$0.74 10-Q · filed 2017-08-09 | ||||
| 2016-03-31 | -$3.23 10-K · filed 2018-03-12 | -$0.32 10-Q · filed 2017-05-10 | |||||
| 2015-12-31 | -$4.38 8-K · filed 2017-12-15 | -$13.63 10-K · filed 2018-03-12 | |||||
| 2015-09-30 | -$3.58 8-K · filed 2017-12-15 | ||||||
| 2015-06-30 | -$2.30 8-K · filed 2017-12-15 | ||||||
| 2015-03-31 | -$3.35 8-K · filed 2017-12-15 | ||||||
| 2014-12-31 | -$4.49 8-K · filed 2017-12-15 |